
Terremoto Biosciences Appoints Charles Baum as CEO
US biotechnology company Terremoto Biosciences has appointed Charles Baum CEO. He succeeds Peter Thompson, who will continue to serve as Terremoto’s board chairperson.

US biotechnology company Terremoto Biosciences has appointed Charles Baum CEO. He succeeds Peter Thompson, who will continue to serve as Terremoto’s board chairperson.

Veranova, a development and manufacturing of specialist and complex APIs for the pharmaceutical and biotech sectors, recently announced the appointment of Cécile Maupas as Senior Vice President, Chief Commercial Officer.

Actylis, a global manufacturer and sourcing expert of critical materials and performance ingredients for the life sciences and specialty chemicals markets formed in 2022, appointed Scott Thomson as new Chief Executive Officer.

Neste has appointed Heikki Malinen as president and CEO of Neste, effective Nov. 2, 2024, at the latest. He succeeds Matti Lehmus, who decided to leave the company. Malinen is currently a member of Neste’s board of directors, but will step down before taking up his new role.

Ilham Kadri, CEO of Syensqo, takes on the role as president of the European Chemical Industry Council (CEFIC), succeeding Martin Brudermueller, effective today.

Lonza has appointed Wolfgang Wienand as its new CEO. He will join the company during the summer of 2024 and succeed Albert M. Baehny, who took on the additional responsibility of interim CEO in October 2023 while the search for a permanent CEO took place.

US specialty chemicals and materials company Chemours has appointed Denise Dignam as the company’s permanent CEO and president, as well as a member of the board of directors, effective immediately.

Sasol has appointed Antje Gerber as executive vice president Chemicals and member of the group executive committee, effective April 15, 2024. She will succeed Brad Griffith, who is to retire on June 30, 2024.

Unilever has appointed Heiko Schipper as President of the group’s Nutrition business, effective May 1, 2024.

Siegfried has appointed Marianne Späne, currently chief business officer Drug Products, as chief business officer with responsibility for both the Drug Substances and Drug Products divisions of the Swiss contract manufacturing and development organization (CDMO), effective Feb. 1, 2024. Christian Dowdeswell, who previously led the Drug Substance business, has decided to leave Siegfried.

Veranova has appointed Chris Holmes as the company’s first vice president, Global Engineering. He will lead Veranova’s global engineering team in the planning, design, and execution of the company’s capital investment initiatives and lead strategic capital projects.

IMCD has appointed Natasha De Lange as managing director for South Africa, effective Feb. 1, 2024. She will be replacing Ryan Harrison, who will become managing director of Australia and New Zealand.

BP has appointed Murray Auchincloss as its permanent CEO, effective immediately. He has been interim CEO since September 2023 after the sudden resignation of his predecessor Bernard Looney.

International Flavors & Fragrances (IFF) has appointed J. Erik Fyrwald as next CEO and member of the company’s board of directors, effective Feb. 6, 2024. He will succeed Frank Clyburn, who will remain with the IFF until the end of March and will continue to work in an advisory capacity until December 2024.

IMCD has appointed Fenna van Zanten, IMCD Group Director, Mergers & Acquisitions (M&A), and Andreas Igerl, President, IMCD APAC, as new members to its executive committee, effective Jan. 1, 2024.

EuroAPI has appointed Ludwig de Mot as chief transformation officer and executive vice president (EVP).

US API maker Veranova has appointed Lucas Sauer-Jones as the company’s vice president & general manager, New England. He will be responsible for Veranova’s sites in Devens and North Andover.

Arkema board of directors has unanimously expressed its confidence in the company’s chairman and CEO Thierry Le Hénaff to execute the strategy announced during Arkema’s capital markets day on Sep. 27 and proposed the renewal of his term of office for four years at the company’s next annual shareholders meeting in May 2024.

EuroAPI's Board of Directors decided that Karl Rotthier would step down as CEO, effective October 30, 2023. They initiated the search for a new CEO and appointed Viviane Monges, the current Board Chair, as interim CEO until a permanent successor is found, while she continues her role as Board Chair.

The Board of Directors at Syngenta Group has appointed Hengde Qin as the new Chief Financial Officer, starting from December 1, 2023. Qin will take over from Chen Lichtenstein who has served as CFO since Syngenta Group's inception but is now leaving to explore other business ventures.

Jeff Rowe will become Syngenta Group's CEO on January 1, 2024, transitioning from his current role as President of Syngenta Crop Protection. The current CEO, Erik Fyrwald, will retire at the end of the year after almost seven and a half years with the company. After retiring, Fyrwald will act as an Advisor to the Chairman of Syngenta Group and retain his position on the Board of Directors.

UK-headquartered drug development and manufacturing organization (CDMO) Quotient Sciences has appointed Thierry Van Nieuwenhove as its new CEO, effective Oct. 16, 2023. He succeeds Mark Egerton who retires after 18 years in this role.

Contract development and manufacturing organization (CDMO) AmbioPharm has appointed industry veteran Brian Gregg as CEO. Gregg, who has more than 30 years of experience in the peptide CDMO industry, succeeds Tim Nieters, who will be stepping down after seven years with the company.

Borealis has appointed two vice presidents within its polyolefins business unit, effective Sep. 1, 2023.

US contract development and manufacturing organization (CDMO) Veranova has appointed William Sanders as global vice president of chemical development operations, effective Sep. 18, 2023.

North American contract manufacturer Jubilant HollisterStier has appointed Ian Fuller as its new vice president of Operations.

Specialty chemicals and food ingredients distributor Azelis has appointed Evy Hellinckx as CEO of Azelis EMEA, effective Jan. 1, 2024. She succeeds Anna Bertona, who will take on her new role as Azelis Group CEO at the beginning of next year.

Barentz has appointed Peter Boone as its new CEO, effective Oct. 1, 2023. He succeeds Hidde van der Wal, who is to retire after leading the company more than 20 years.

Veranova announced the appointment of Victoria Brown as the company’s SVP, Chief Human Resources Officer (CHRO) based in Devens, MA, US.

Maurizio Sartorato has joined international API supplier Olon as Vice President of the group's Biotech division. In his new role, he will be a member of Olon’s leadership team.

Germany-headquartered healthcare company Fresenius Medical Care has appointed Martin Fischer as its new chief financial officer, effective Oct. 1, 2023.

Ingenza has appointed Steve Jones as chief financial officer (CFO), effective immediately.

Hanno Scheffczik has been appointed as the new Managing Director of Temmler Pharma, a member of the Aenova Group. Effective Mar. 1, 2023, he succeeds Alfred Veit, who is retiring.

Bowing to growing pressure from activist investors with different missions, the supervisory board of tradition-steeped German pharmaceuticals and agrochemicals player Bayer has announced the appointment of a new CEO to succeed embattled incumbent Werner Baumann — a year before the end of the current chief executive’s regular term.

From next year, GSK’s top management will be led by a double female team, a pioneering move for the global pharmaceutical industry. The UK drugs giant this week announced the appointment of Julie Brown, the first woman to be its chief financial officer.























